Retinoic Acid Receptor Alpha (RARA) positive
Showing 51 - 75 of >10,000
Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)
Not yet recruiting
- Hematologic Malignancy
- +21 more
- Fludarabine
- +4 more
- (no location specified)
Feb 9, 2023
Ulcerative Colitis Trial ("Mesalamine" and "alpha-lipoic acid", "Mesalamine" and "Placebo")
Not yet recruiting
- Ulcerative Colitis
- "Mesalamine" and "alpha-lipoic acid"
- "Mesalamine" and "Placebo"
- (no location specified)
Oct 5, 2023
Hypertriglyceridemia Trial in Tehran (Control, Omega-3 supplementation, Chia seed)
Not yet recruiting
- Hypertriglyceridemia
- Control
- +2 more
-
Tehran, Iran, Islamic Republic ofClinical Nutrition Research Unit, National Nutrition and Food Te
Sep 3, 2023
Pompe Disease, Muscle Loss, Obesity Trial (Multi-ingredient supplement (PDT-MIS), Placebo (PLA))
Not yet recruiting
- Pompe Disease
- +7 more
- Multi-ingredient supplement (PDT-MIS)
- Placebo (PLA)
- (no location specified)
Nov 8, 2023
Older Women With ER Positive, HER2 Negative Early Breast Cancer
Enrolling by invitation
- Breast Cancer Female
- Translational study
-
Sutton, United KingdomThe Royal Marsden NHS Foundation Trust
Feb 8, 2023
Liver Regeneration, Ursodeoxycholic Acid, Partial Liver Resection Trial in New Delhi (Ursodeoxycholic acid, Standard Medical
Not yet recruiting
- Liver Regeneration
- +2 more
- Ursodeoxycholic acid
- Standard Medical Treatment
-
New Delhi, IndiaInstitute of Liver and Biliary Sciences
Oct 18, 2023
Brain Tumors Trial in Canada, United States (temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid)
Completed
- Brain Tumors
- temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid
-
Phoenix, Arizona
- +16 more
Jun 17, 2021
Colorectal Cancer Trial (all trans Retinoic Acid, Atezolizumab, Bevacizumab)
Not yet recruiting
- Colorectal Cancer
- all trans Retinoic Acid
- +2 more
- (no location specified)
Aug 11, 2023
Acute Myeloid Leukemia Trial in Valencia (AFM28)
Recruiting
- Acute Myeloid Leukemia
-
Valencia, SpainHospital Universitari i Politècnic La Fe
Apr 5, 2023
Breast Tumors Trial in Beijing, Nanjing, Changsha (Disitamab Vedotin, Toripalimab)
Not yet recruiting
- Breast Neoplasms
- Disitamab Vedotin
- Toripalimab
-
Beijing, Cancer Hospital Chinese Academy Of Medical Sciences, China
- +2 more
Oct 23, 2023
G6PD Deficiency, Carbohydrate Metabolism Disorder, Oxidative Stress Trial (Alpha-lipoic acid, Placebo)
Not yet recruiting
- G6PD Deficiency
- +2 more
- Alpha-lipoic acid
- Placebo
- (no location specified)
Jan 2, 2023
Breast Cancer Stage IV Trial in Irvine (Gallium-68)
Recruiting
- Breast Cancer Stage IV
-
Irvine, CaliforniaHoag Memorial Hospital Presbyterian
May 26, 2023
CYP2D6 Polymorphism Trial in Seattle (Isotretinoin, dextromethorphan)
Active, not recruiting
- CYP2D6 Polymorphism
-
Seattle, WashingtonUniversity of Washington
Sep 27, 2021
Hair Diseases, Alopecia, Hair Loss Trial in Manaus (DA-OTC-002)
Completed
- Hair Diseases
- +2 more
- DA-OTC-002
-
Manaus, BrazilHospital Oscar Nicolau
Oct 20, 2023
Cervical Dysplasia, HPV Infection Trial in Ulaanbaatar (gel Interferon arm, gel Interferon and interferon suppository arm)
Recruiting
- Cervical Dysplasia
- HPV Infection
- gel Interferon arm
- gel Interferon and interferon suppository arm
-
Ulaanbaatar, MongoliaNational Cancer Center
Nov 14, 2023
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine plus Bevacizumab, Bevacizumab)
Recruiting
- Ovarian Cancer
- +2 more
- Mirvetuximab soravtansine plus Bevacizumab
- Bevacizumab
-
New Orleans, Louisiana
- +3 more
Dec 16, 2022
Diabetic Neuropathies, Diabetes, Dietary Supplement Trial in Thessaloníki (Epineuron, Placebo group)
Completed
- Diabetic Neuropathies
- +2 more
- Epineuron
- Placebo group
-
Thessaloníki, Thessaloniki, GreeceUniversity General Hospital AHEPA
Aug 8, 2023
Allergy to Cats, Allergic Rhinoconjunctivitis Trial in Berlin (holoBLG)
Completed
- Allergy to Cats
- Allergic Rhinoconjunctivitis
- holoBLG
-
Berlin, GermanyECARF Institute GmbH
Jul 8, 2022
Schizophrenia, Oxidative Stress Trial in Fortaleza (Alpha-lipoic acid, Placebo Oral Tablet)
Completed
- Schizophrenia
- Oxidative Stress
- Alpha-lipoic acid
- Placebo Oral Tablet
-
Fortaleza, CE, BrazilNúcleo de Pesquisa e Desenvolvimento de Medicamentos - UFC
Aug 26, 2022
Basic Science Trial in Copenhagen (Lysergic Acid Diethylamide Tartrate)
Not yet recruiting
- Basic Science
- Lysergic Acid Diethylamide Tartrate
-
Copenhagen, DenmarkNeurobiology Research Unit, Rigshospitalet
Jul 11, 2023